Table 2.
Demographics and sample characteristics for the treatment groups and control group.
|
iCBT n = 39 |
MEiCBT n = 40 |
iMT n = 40 |
TAU n = 39 |
Statistic | |||||
|---|---|---|---|---|---|---|---|---|---|
| M(SD) | Range | M(SD) | Range | M(SD) | Range | M(SD) | Range | ||
| Age (years) | 36.69(11.53) | 21–60 | 41.38(13.30) | 19–69 | 37.10(12.35) | 21–71 | 41.69(10.75) | 23–63 | F(3, 154) = 1.97, p = .12 |
| n | % | n | % | n | % | n | % | ||
| Gender | |||||||||
| Male | 6 | 15.4 | 4 | 10.0 | 6 | 15.0 | 6 | 15.4 | χ2 (3) = 0.69, p = .88 |
| Female | 33 | 84.6 | 36 | 90.0 | 34 | 85.0 | 33 | 84.6 | |
| Marital status | |||||||||
| Single/never married | 13 | 33.3 | 16 | 40 | 15 | 37.5 | 10 | 25.6 | χ2 (15) = 12.6, p = .63 |
| Married/de-facto | 19 | 48.7 | 17 | 42.5 | 21 | 52.5 | 20 | 51.3 | |
| Separated/divorced/widowed | 7 | 17.9 | 7 | 17.5 | 4 | 10 | 9 | 23.1 | |
| Educational status | |||||||||
| No qualification | 4 | 10.3 | 1 | 2.5 | 4 | 10 | 3 | 7.7 | χ2 (27) = 24.08, p = .63 |
| High school | 5 | 12.8 | 5 | 12.5 | 3 | 7.5 | 7 | 17.9 | |
| Tertiary (Undergraduate) | 18 | 46.2 | 23 | 57.5 | 21 | 52.5 | 18 | 46.2 | |
| Tertiary (Postgraduate) | 4 | 10.3 | 5 | 12.5 | 7 | 17.5 | 6 | 15.4 | |
| Technician, trade, or other certificate | 8 | 20.5 | 6 | 15 | 5 | 12.5 | 5 | 12.8 | |
| Employment status | |||||||||
| At home parent | 2 | 5.1 | 0 | 0 | 0 | 0 | 1 | 2.6 | χ2 (27) = 31.50, p = .25 |
| Full-time paid work | 13 | 33.3 | 13 | 32.5 | 14 | 35.0 | 17 | 43.6 | |
| Part-time paid work | 14 | 35.9 | 14 | 35.0 | 17 | 42.5 | 8 | 20.5 | |
| Unemployed | 3 | 7.7 | 7 | 17.5 | 3 | 7.5 | 7 | 18.0 | |
| Student | 7 | 17.9 | 3 | 7.5 | 4 | 10.0 | 3 | 7.7 | |
| Retired | 0 | 0 | 3 | 7.5 | 1 | 2.5 | 1 | 2.6 | |
| Disabled | 0 | 0 | 0 | 0 | 1 | 2.5 | 1 | 2.6 | |
| Current medications | 15 | 38.5 | 16 | 40.0 | 18 | 45.0 | 15 | 38.5 | χ2 (3) = 0.48, p = .92 |
| Current medications (Type) | χ2 (9) = 6.80, p = .66 | ||||||||
| SSRI | 9 | 23.1 | 10 | 25 | 10 | 25 | 4 | 10.3 | |
| SNRI | 5 | 12.8 | 3 | 7.5 | 6 | 15 | 7 | 17.9 | |
| Other | 1 | 2.6 | 3 | 7.5 | 2 | 5 | 4 | 10.3 | |
| Current CBT treatment | 3 | 7.7 | 3 | 7.5 | 2 | 5.0 | 2 | 5.1 | χ2 (3) = 0.42, p = .93 |
| Previous experience with CBT | 16 | 41.0 | 12 | 30.0 | 9 | 22.5 | 15 | 38.5 | χ2 (3) = 3.82, p = .28 |
| Previous experience with mindfulness | 30 | 76.9 | 27 | 67.5 | 25 | 62.5 | 31 | 79.5 | χ2 (3) =3.69, p = .30 |
| M(SD) | Range | M(SD) | Range | M(SD) | Range | M(SD) | Range | ||
| Perceived credibility of treatment | 6.71 (1.86) | 1–9 | 7.29 (1.99) | 2–9 | 7.40 (1.62) | 5–9 | n/a | n/a | F(2, 108) = 1.53, p = .22 |
| Expectancy of benefit | 5.40 (1.64) | 1–9 | 5.89 (1.83) | 2–9 | 5.90 (1.54) | 2–9 | n/a | n/a | F(2, 108) = 1.11, p = .34 |
| n | % | n | % | n | % | n | % | ||
| Pre-treatment primary diagnosis | |||||||||
| MDD | 12 | 30.8 | 13 | 32.5 | 12 | 30.0 | 9 | 23.1 | χ2 (3) = 0.98, p = .81 |
| GAD | 12 | 30.8 | 11 | 27.5 | 17 | 42.5 | 19 | 48.7 | χ2 (3) = 4.99, p = .17 |
| SAD | 12 | 30.8 | 12 | 30.0 | 7 | 17.5 | 8 | 20.5 | χ2 (3) = 2.86, p = .41 |
| PD | 1 | 2.6 | 1 | 2.5 | 3 | 7.5 | 1 | 2.6 | χ2 (3) = 2.01, p = .57 |
| AG | 1 | 2.6 | 0 | 0 | 0 | 0 | 2 | 5.1 | χ2 (3) = 3.83, p = .28 |
| OCD | 1 | 2.6 | 3 | 7.5 | 1 | 2.5 | 0 | 0 | χ2 (3) = 3.83, p = .28 |
Note. Except where noted, values refer to number and percentage scores. Educational Status = highest level of education received. iCBT = internet-delivered CBT; MEiCBT = Mindfulness-Enhanced iCBT; iMT = internet-delivered Mindfulness Training; TAU = Treatment as Usual. M = mean, SD = standard deviation. SSRI = Selective Serotonin Reuptake Inhibitor; SNRI = Selective Norepinephrine Reuptake Inhibitor; CBT = Cognitive Behavioural Therapy; MDD = Major Depressive Disorder; GAD = Generalised Anxiety Disorder; SAD = Social Anxiety Disorder; PD = Panic Disorder; AG = Agoraphobia; OCD = Obsessive Compulsive Disorder.